Trials
Search / Trial NCT06443879

Loss and Return of Sensation After Axillary Brachial Plexus Nerve Block - Distally or Proximally

Launched by BALGRIST UNIVERSITY HOSPITAL · May 30, 2024

Trial Information

Current as of February 19, 2025

Completed

Keywords

Peripheral Regional Anesthesia Loss And Return Of Sensation

ClinConnect Summary

Peripheral regional anesthesia is the current gold standard of opioid-sparing perioperative analgesia, especially in shoulder, upper limb, and leg surgery.(1-8) Axillary brachial plexus nerve block is one possible block for upper limb surgery.(4, 5, 9) Loss and return of sensation require time. It is known from clinical practice that loss of sensation occurs from the proximal part of the arm to the distal part of the upper limb.

Interestingly, until now there is no study about the return of sensation related to the anatomic region. The investigators hypothesize that return of sensation aft...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Outpatients with planed surgery with axillary brachial plexus nerve block
  • Informed consent as documented by signature
  • Age ≥ 18 years
  • Exclusion Criteria:
  • Patients with a known allergy towards the local anaesthetic

Trial Officials

Hagen Bomberg, Dr.med.

Principal Investigator

Balgrist University Hospital

About Balgrist University Hospital

Balgrist University Hospital is a leading academic medical center based in Zurich, Switzerland, renowned for its expertise in musculoskeletal health and rehabilitation. As a prominent sponsor of clinical trials, the hospital is dedicated to advancing medical research and improving patient outcomes through innovative studies in orthopedics, neurology, and rehabilitation sciences. With a strong commitment to interdisciplinary collaboration and patient-centered care, Balgrist University Hospital leverages its state-of-the-art facilities and a team of experienced researchers to drive clinical advancements and foster the translation of scientific discoveries into practical therapies.

Locations

Zürich, Zurich, Switzerland

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0